Skip to main content
Equibles
LFCR logo

LFCR · Lifecore Biomedical, Inc. De · Metrics

Track LFCR — free

Use LFCR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LFCR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.09 -0.22 (-5.10%) At close · Sep 9
Russell 2000 member Rebalance outlook locked
Market Cap
$156.90M
Shares
37.85M

LFCR metrics

51 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.09
Market cap
$156.90M

Price action

20 metrics
Price change (1W)
-1.8%
Price change (30D)
-7.5%
Price change (3M)
-23.9%
Price change (6M)
-37.5%
Price change (YTD)
-47.3%
Price change (1Y)
-40.9%
Trailing year
Price change (5Y)
-59.3%
52-week high
$8.82
52-week low
$3.66
Change from 52-week high
-51.1%
Change from 52-week low
+17.8%
Annualized volatility
61.1%
Annualized volatility (3M)
52.1%
Beta
0.9
RSI (14D)
42.1
Price vs SMA 50
-6.9%
Price vs SMA 200
-27.1%
Avg volume (3M)
169,980
Relative volume
1.1
Average dollar volume
$833,371

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
37.85M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.0×
reciprocal yield 49.3%
EV / revenue historical average (5Y)
1.5×
reciprocal yield 67.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
31.3%
Operating margin
-13.4%
Trailing 12 months
Net margin
-30.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.76

Growth

11 metrics
Revenue growth YoY
+0.5%
Year over year
Net income growth YoY
-422.3%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-484.8%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.0%
Revenue CAGR (5Y)
-4.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-2,898.0%
Return on assets
-16.2%
Debt / equity
—
Current ratio
3.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$17.24M
Total assets
$229.50M
Total debt
$156.04M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
100
13F filer change QoQ
-6
Institutional ownership
67.4%

Short interest

3 metrics
Short interest
6.4%
Latest settlement · 17.4 days to cover
Days to cover
17.4d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1005286 CUSIP 514766104 13F (30d) 66 filings 66 filers Visit website Investor relations